Point-of-Care Diagnostic Platform LumiraDx™
The LumiraDx Platform is an innovative, next generation point of care system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity
Product Specifications
Description
Enzyme and immunoassay on a single platform
Its proprietary technology enables it to deliver exceptional point of care clinical performance, while being simple and easy to use
Performance referenced to laboratory test
Portable instrument, seamless connectivit
One simple, intuitive test workfow
Fast results in minutes
All common clinical samples
Small sample size including capillary blood
Ability to perform Quality Control Tests using LumiraDx Quality Control to meet regulatory compliance requirements
2 x USB ports, RFID reader 13.56 MHz, 0 dBi (EIRP), Bluetooth low-energy 2.4 GHz ISM band, 2400 MHz to 2483.5 MHz, 0.5 dBm (ERP)
Lithium ion polymer 7.4 V 5000 mAh battery
High contrast touchscreen with a wide viewing angle
Uses small sample volumes and multiple convenient sample types, including nasal swab and capillary blood
Pipeline of 30+ assays, initially focused on some of the most common conditions being diagnosed or managed with POC testing
The LumiraDx SARS-CoV-2 Ag Test has been authorized by FDA under an EUA only for the detection of SARS-CoV-2 nucleocapsid protein
The LumiraDx SARS-CoV-2 Ab Test has been authorized by FDA under an EUA only for detecting the presence of total antibodies to SARS-CoV-2